Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Category Archives: Top 20 Shareholders

Top 20 Shareholders December 2022

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustJanuary 1, 2023

Top_Holders_Report DEC

Top 20 Shareholders November 2022

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAustDecember 1, 2022

Top_Holders_Report NOV

Top 20 Shareholders October 2022

Top 20 ShareholdersBy PharmAustNovember 1, 2022

Top_Holders_Report OCT

Top 20 Shareholders

Top 20 ShareholdersBy PharmAustSeptember 30, 2022

Top_Holders_Report (1)

Top 20 Shareholders

Top 20 ShareholdersBy PharmAustAugust 1, 2022

Top_Holders_Report (4)

July 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustJuly 1, 2022

220701_Top_Holders_Report (5)

June 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustJune 1, 2022

220601_Top_Holders_Report (2)

May 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustMay 1, 2022

200430_Top_Holders

April 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustApril 1, 2022

220401_Top_Holders_Movements_Report

March 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustMarch 1, 2022

220315_Top_Holders

→123456→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube
TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
15 Mar

Pet care sector’s nothing to sniff at https://www.heraldsun.com.au/business/victoria-business/tim-boreham-australian-pet-care-sector-is-nothing-to-sniff-at/news-story/b508df6b5abc1f1271607dfaf42ccf06 via @theheraldsun

Reply on Twitter 1636148718847299584 Retweet on Twitter 1636148718847299584 2 Like on Twitter 1636148718847299584 8 Twitter 1636148718847299584
Retweet on Twitter PharmAust Retweeted
asxdecks ASX Decks @asxdecks ·
15 Mar

Pharmaust Limited $PAA $PAA.AX

New #ASX investor presentation: PharmAust Investor Webinar Presentation

Questions / feedback for ASX:PAA? Ask at https://tinyurl.com/25vr9ujv?entry.96502678=PAA

Reply on Twitter 1636120690091868161 Retweet on Twitter 1636120690091868161 2 Like on Twitter 1636120690091868161 2 Twitter 1636120690091868161
pharmaust PharmAust @pharmaust ·
15 Mar

🚨 Reminder that $PAA/@PharmAust Executive Chairman, Dr Roger Aston will be presenting TODAY as part of the free @broker_briefing Biotech & Nutrition Investor Webinar

Register here 👇
https://us06web.zoom.us/webinar/register/1716606999117/WN_Hwj9PbRTRE2qtdPZ0rtPSA

Reply on Twitter 1636115496323149824 Retweet on Twitter 1636115496323149824 2 Like on Twitter 1636115496323149824 8 Twitter 1636115496323149824
Load More
Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top